Celebrating World Theranostics Day with Theranostics Expert Dr. Harshad Kulkarni

In this special World Theranostics Day episode, Christine VanTimmeren and Dr. Brandon Mancini are joined by Dr. Harshad Kulkarni, Chief Medical Advisor at BAMF Health and a global leader in theranostics, to discuss how this innovative approach is transforming cancer care and beyond.We break down what theranostics is, how it combines diagnostics and targeted therapy, and why it represents one of the most powerful shifts toward truly personalized medicine. Dr. Kulkarni shares his global experience, insights from early adoption in Europe, and how theranostics is rapidly expanding in the United States.We also explore the growing pipeline of clinical trials, the role of imaging in selecting the right patients, and how this approach is improving patient outcomes, quality of life, and survival. Finally, we look ahead to the future—where theranostics could extend beyond cancer into diseases like cardiovascular disease, Parkinson's, and more.00:00 Intro & World Theranostics Day 00:41 What Theranostics Means 02:19 Meet Dr. Harshad Kulkarni 02:54 How Dr. Kulkarni Entered Theranostics 04:20 How Europe Advanced Theranostics Earlier Than the U.S. 08:12 Why Imaging Is Essential to Theranostics 09:59 “See What You Treat, Treat What You See” 12:30 FDA-Approved Theranostics Today 15:59 Beyond Cancer: Alzheimer’s, Cardiology, and More 17:43 Why Theranostics Isn’t Available for Every Cancer Yet 21:46 Real Patient Outcomes & Quality of Life 25:34 What’s Next for Theranostics 27:11 Closing Thoughts & Learn MoreConnect with the hosts on LinkedInDr. Brandon ManciniChristine VanTimmerenConnect with BAMF HealthOur WebsiteOur Podcast